Credit: Original article published here.CardioNerds correspondents Drs. Shiva Patiolla and Jeff Wang are covering The Houston Shock Symposium 2023. They are joined by the founder and director of the Houston Shock Symposium, Dr. Marwan Jumean, and Dr. Anju Bhardwaj, who currently serves as an assistant professor of medicine in the section of cardiology at the McGovern Medical School. The group discusses the theme of this year’s symposium, which is Breaking Boundaries, and will focus on the five areas of cardiogenic shock management, which are: Cardiac ICU, Cath Lab, Medical ICU, Operating Room, and Surgical ICU. See what these thought leaders had to say! Dr. Shiva Patiolla: Hello, everyone and thank you for joining us today. I am Shiva Patiolla. I’m a cardiology fellow at Baylor University Medical Center in Dallas, Texas, and a CardioNerds FIT Trialist. Dr. Jeff Wang: All right. Hi, everyone. My name is Jeff Wang, and I am a cardiology fellow at Emory University and a CardioNerds FIT Trialist as well. And we are really excited to serve as CardioNerds Conference Scholars for the 2023 Houston Shock Symposium with mentorship from Dr. Andrew Higgins. Dr. Shiva Patiolla: It is our great pleasure to be joined by the

Credit: Original article published here.A fasting diet that emphasizes eating early in the day may reduce the risk of developing type 2 diabetes. The findings were reported in Nature Medicine. To conduct this study, researchers compared two different diets: one, a time restricted, intermittent fasting diet, and the other a reduced calorie diet. The 18-month study consisted of 200 participants from South Australia. While participants in both study groups experienced weight loss, the time restricted diet yielded better results as it pertains to diabetes protection. “Following a time restricted, intermittent fasting diet could help lower the chances of developing type 2 diabetes,” said senior author the University of Adelaide’s Professor Leonie Heilbronn, Adelaide Medical School via a press release about the study. “People who fasted for three days during the week, only eating between 8am and 12pm on those days, showed a greater tolerance to glucose after 6 months than those on a daily, low-calorie diet.” “Participants who followed the intermittent fasting diet were more sensitive to insulin and also experienced a greater reduction in blood lipids than those on the low-calorie diet.” “This is the largest study in the world to date and the first powered to assess how

Credit: Original article published here.This year, the CardioNerds are covering the 2023 Houston Shock Symposium, or HSS23. In this interview, CardioNerds Conference Scholars Drs. Tommy Das (Cleveland Clinic), and Katie Vaughan (Israel Deaconess Medical Center) spoke with Dr. Dan Burkhoff, who’ll be presenting the teaching and education in advanced cardiovascular hemodynamics course, or TEACH course for HSS23 attendees. Dr. Burkhoff spoke in-depth about Harvi, which is interactive simulation based application developed for teaching and researching many aspects of ventricular mechanics and hemodynamics. See what the CardioNerds and Dr. Burkhoff had to say. Dr. Tommy Das: Hi, everyone. My name is Tommy Das. I’m a current second year general cardiology fellow at the Cleveland Clinic, and Service Program Director for the CardioNerds Academy, a fellowship in digital medical education. Dr. Katie Vaughan: And my name is Katie Vaughan, and I’m a chief resident at Beth Israel Deaconess Medical Center, where I will remain for cardiology fellowship next year. And I’m a CardioNerds scholar for my project to create a curriculum to teach trainees all about different mechanical circulatory support devices called Devices in a Dash. And we are so excited to serve as CardioNerds’ conference scholars for the 2023 Houston Shock

Credit: Original article published here.Getting a good night’s sleep is already known to be essential for maintaining overall health; however, according to a study presented at the American College of Cardiology’s Annual Scientific Session Together With the World Congress of Cardiology, it could potentially add years to your life. The study found that young people who have more beneficial sleep habits are incrementally less likely to die early. Furthermore, the data suggest that poor sleep patterns may contribute to about 8% of deaths from any cause. Highlighting the importance of getting restful sleep and not just enough hours of sleep, Frank Qian, MD, an internal medicine resident physician at Beth Israel Deaconess, stated in a recent press release: “We saw a clear dose-response relationship, so the more beneficial factors someone has in terms of having higher quality of sleep, they also have a stepwise lowering of all cause and cardiovascular mortality.” The study included data from 172,321 participants from the National Health Interview Survey between 2013 and 2018. The survey, fielded each year  by the Centers for Disease Control and Prevention, includes questions pertaining to obtaining information about sleep and sleep habits. According to the researchers, this study is the

Credit: Original article published here.Baxdrostat, a new hypertension medication undergoing Phase 2 trials, was not associated with a reduction in blood pressure when compared to placebo in patients with resistant hypertension, according to results from the newly released HALO trial. The role of hypertension and adverse health outcomes has been well established in the medical literature. Concerningly, an estimated 10 million Americans suffer from “treatment resistant hypertension,” or uncontrolled blood pressure despite at least three blood-pressure lowering medications (Carey et al). The need for pharmacotherapy in this population is critical, explained a speaker at 2023 American College of Cardiology (ACC) Scientific Session. Dr. Deepak Bhatt, MD, MPH, the Director of Mount Sinai Heart, described the results of the HALO trial, a phase 2 randomized controlled trial evaluating the efficacy of baxdrostat at the ACC Scientific Session in New Orleans, LA. Resistant hypertension has been strongly linked to the renin-angiotensin-aldosterone system, with observational data demonstrating the role of aldosterone excess in contributing to high blood pressure. Prior randomized controlled trials (PATHWAY-2) and metanalyses showed that mineralocorticoid receptor antagonists (MRAs), which block the effect of aldosterone, were among the most effective medications at reducing blood pressure (Yugar Toledo et al). This led